CellChorus

About:

CellChorus applies visual AI to evaluate how individual cells move, behave, and interact.

Twitter/X: cellchorus

Top Investors: Y Combinator, Texas HALO Fund, Asymmetry Ventures, National Institute of General Medical Science, NCATS

Description:

CellChorus provides a comprehensive, dynamic analysis of single cells for biopharmaceutical companies. The company’s TIMING™ platform applies visual AI to evaluate cell activation, killing and movement as a function of time in order to maximize our understanding of the cellular function, state, and phenotype of immuno-oncology and other therapies.

Total Funding Amount:

$4.93M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

South San Francisco, California, United States

Founded Date:

2017-09-01

Contact Email:

TIMING(AT)cellchorus.com

Founders:

Dan Meyer

Number of Employees:

1-10

Last Funding Date:

2024-05-02

IPO Status:

Private

Industries: